Cornerstone Capital Management Holdings’s Kyntra Bio KYNB Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.32M	Buy	1,116 +32	+3%	+$40.1K	0.01%	849
2017 Q3	$1.46M	Sell	1,084 -80	-7%	-$84.3K	0.01%	848
2017 Q2	$939K	Buy	1,164 +19	+2%	+$13.2K	0.01%	920
2017 Q1	$705K	Buy	1,145 +1,125	+5,625%	+$685K	0.01%	992
2016 Q4	$10K	Sell	20 -3,323	-99%	-$1.66M	﹤0.01%	1312
2016 Q3	$1.73M	Sell	3,343 -5,231	-61%	-$2.46M	0.01%	808
2016 Q2	$3.52M	Buy	8,574 +2,296	+37%	+$1.05M	0.03%	550
2016 Q1	$3.34M	Buy	6,278 +2,251	+56%	+$1.12M	0.03%	580
2015 Q4	$3.07M	Buy	+4,027	New	+$2.67M	0.03%	602

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Cornerstone Capital Management Holdings's KYNB Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Kyntra Bio (KYNB) stake by 3% in Q4 2017, buying an estimated $40.1K and bringing the position to 1,116 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #849.

Cornerstone Capital Management Holdings first reported a position in KYNB in Q4 2015 and has held it in 9 quarters since. The position peaked at $3.52M in Q2 2016. 187 funds tracked by Wall St. Rank hold KYNB as of Q4 2017.

Cornerstone Capital Management Holdings held 1,116 shares of Kyntra Bio worth $1.32M as of Q4 2017.
Cornerstone Capital Management Holdings bought 32 Kyntra Bio shares in Q4 2017, an estimated $40.1K.
Kyntra Bio made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #849 holding.
Cornerstone Capital Management Holdings first reported a position in Kyntra Bio in Q4 2015 and has held it in 9 quarters since.
Cornerstone Capital Management Holdings's Kyntra Bio position peaked at $3.52M in Q2 2016.
187 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.